Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Titel:
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Auteur:
Meric-Bernstam, Funda Hurwitz, Herbert Raghav, Kanwal Pratap Singh McWilliams, Robert R Fakih, Marwan VanderWalde, Ari Swanton, Charles Kurzrock, Razelle Burris, Howard Sweeney, Christopher Bose, Ron Spigel, David R Beattie, Mary S Blotner, Steven Stone, Alyssa Schulze, Katja Cuchelkar, Vaikunth Hainsworth, John